HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: db07-0332v1 56/10/2551    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Jarchum, I. Articles by DiLorenzo, T. P. Search for Related Content PubMed PubMed Citation Articles by Jarchum, I. Articles by DiLorenzo, T. P. Social Bookmarking                What's this?

In Vivo Cytotoxicity of Insulin-Specific CD8⁺ T-Cells in HLA-A*0201 Transgenic NOD Mice

¹ Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York
² Department of Medicine (Division of Endocrinology), Albert Einstein College of Medicine, Bronx, New York
³ Department of Pediatrics, Division of Genetic and Translational Medicine, University of Alabama at Birmingham, Birmingham, Alabama
⁴ The Jackson Laboratory, Bar Harbor, Maine

Address correspondence and reprint requests to Teresa P. DiLorenzo, PhD, Albert Einstein College of Medicine, Microbiology and Immunology, 1300 Morris Park Ave., Bronx, NY 10461. E-mail: dilorenz{at}aecom.yu.edu

Abbreviations: CFSE, carboxyfluorescein diacetate succinimidyl ester; ELISPOT, enzyme-linked immunospot; IFN, interferon; IGRP, islet-specific glucose-6-phosphatase catalytic subunit-related protein; MHC, major histocompatibility complex

OBJECTIVE—CD8⁺ T-cells specific for islet antigens are essential for the development of type 1 diabetes in the NOD mouse model of the disease. Such T-cells can also be detected in the blood of type 1 diabetic patients, suggesting their importance in the pathogenesis of the human disease as well. The development of peptide-based therapeutic reagents that target islet-reactive CD8⁺ T-cells will require the identification of disease-relevant epitopes.

RESEARCH DESIGN AND METHODS—We used islet-infiltrating CD8⁺ T-cells from HLA-A*0201 transgenic NOD mice in an interferon- enzyme-linked immunospot assay to identify autoantigenic peptides targeted during the spontaneous development of disease. We concentrated on insulin (Ins), which is a key target of the autoimmune response in NOD mice and patients alike.

RESULTS—We found that HLA-A*0201-restricted T-cells isolated from the islets of the transgenic mice were specific for Ins1 L3–11, Ins1 B5–14, and Ins1/2 A2–10. Insulin-reactive T-cells were present in the islets of mice as young as 5 weeks of age, suggesting an important function for these specificities early in the pathogenic process. Although there was individual variation in peptide reactivity, Ins1 B5–14 and Ins1/2 A2–10 were the immunodominant epitopes. Notably, in vivo cytotoxicity to cells bearing these peptides was observed, further confirming them as important targets of the pathogenic process.

CONCLUSIONS—The human versions of B5–14 and A2–10, differing from the murine peptides by only a single residue, represent excellent candidates to explore as CD8⁺ T-cell targets in HLA-A*0201–positive type 1 diabetic patients.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?